Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |